WEBINAR: Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery
May 9, 2017 (1 – 2 p.m. EDT)
This webinar will provide an overview of the R01 and R21 funding opportunity announcements, Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery PA-17-060 (R01) and PA-17-061 (R21).
Dr. Wendy Nelson and Ms. Kathleen Castro provide an overview of these funding opportunities that seek research to assess and describe the current state of oral anticancer medication utilization, delivery, and adherence; identify structural, systemic, and psychosocial barriers to adherence; and develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized.
National Cancer Institute Speakers:
Wendy Nelson, PhD, MPH
Basic Biobehavioral and Psychological Sciences Branch
Behavioral Research Program
Kelly Filipski, PhD, MPH
Clinical and Translational Epidemiology Branch
Epidemiology and Genomics Research Program
Kathleen Castro, RN, MS, AOCN®
Office of the Associate Director
Healthcare Delivery Research Program
Extramural investigators at junior, mid-, and senior levels.
Email your questions in advance to email@example.com. Questions about specific aims or grant application details will not be addressed.
Last Updated: 08 Aug 2017